ReviewJournal of cellular and molecular medicine2020

The rapidly advancing Class 2 CRISPR-Cas technologies: A customizable toolbox for molecular manipulations.

Jingyi Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.